Cargando…
Growth factors in idiopathic pulmonary fibrosis: relative roles
Treatment of idiopathic pulmonary fibrosis patients has evolved very slowly; the fundamental approach of corticosteroids alone or in combination with other immunosuppressive agents has had little impact on long-term survival. The continued use of corticosteroids is justified because of the lack of a...
Autores principales: | Allen, Jeremy T, Spiteri, Monica A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC64811/ https://www.ncbi.nlm.nih.gov/pubmed/11806848 http://dx.doi.org/10.1186/rr162 |
Ejemplares similares
-
Connective Tissue Growth Factor in Idiopathic Pulmonary Fibrosis: Breaking the Bridge
por: Effendi, Wiwin Is, et al.
Publicado: (2022) -
The role of pirfenidone in the treatment of idiopathic pulmonary fibrosis
por: Cottin, Vincent
Publicado: (2013) -
The Role of Microbiome and Virome in Idiopathic Pulmonary Fibrosis
por: Ntolios, Paschalis, et al.
Publicado: (2021) -
Relative Roles of TGF-β and IGFBP-5 in Idiopathic Pulmonary Fibrosis
por: Sureshbabu, A., et al.
Publicado: (2011) -
Idiopathic pulmonary fibrosis
por: Meltzer, Eric B, et al.
Publicado: (2008)